4.7 Article

Comparing plasma and skin imprint metabolic profiles in COVID-19 diagnosis and severity assessment

Related references

Note: Only part of the references are listed.
Article Virology

An overview on the treatments and prevention against COVID-19

Yunes Panahi et al.

Summary: This article summarizes potential therapeutic agents, including antiviral agents, biologic agents, anti-inflammatory agents, and herbal agents, in the treatment of COVID-19. It also discusses various vaccine candidates and platforms being used for the development of COVID-19 vaccines.

VIROLOGY JOURNAL (2023)

Article Immunology

Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients

Ignacio Piedrola et al.

Summary: Antibodies to lipids play a crucial role in the defense against SARS-CoV-2, and their levels are associated with the severity of the disease. Patients with mild cases have lower levels of anti-lipid antibodies and higher levels of inflammatory mediators compared to severe cases. These findings provide novel prognostic biomarkers and potential therapeutic targets.

FRONTIERS IN IMMUNOLOGY (2023)

Review Endocrinology & Metabolism

No skin off your back: the sampling and extraction of sebum for metabolomics

C. Gehin et al.

METABOLOMICS (2023)

Article Multidisciplinary Sciences

Metabolomics study of COVID-19 patients in four different clinical stages

Alberto Valdes et al.

Summary: This study aims to provide new information about the altered biomolecule profile and biological pathways in patients with SARS-CoV-2 infection. Metabolomics analysis of plasma samples from COVID-diagnosed patients revealed potential biomarkers for distinguishing between different clinical stages of the disease. The levels of these biomarkers normalized at hospital discharge, suggesting their potential as early prognosis biomarkers in COVID-19.

SCIENTIFIC REPORTS (2022)

Article Endocrinology & Metabolism

Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients

Helena Castane et al.

Summary: The study found that COVID-19 infection shares many lipid alterations with other infectious/inflammatory diseases, but there are also some differences. The most notable alterations were observed in oxylipins in COVID-19 patients, while bile acids and glycerophospholipids best distinguished between COVID-19-positive and COVID-19-negative patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2022)

Article Microbiology

Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients

Veronica Ghini et al.

Summary: By comparing the plasma composition of COVID-19 patients in the acute phase and recovered individuals, the study found that metabolite biomarkers can serve as timely indicators of treatment response or spontaneous healing. The research also revealed significant alterations in the concentrations of metabolites and lipoproteins in response to COVID-19 infection. Furthermore, the metabolome reverts back to a healthy state faster than the lipoproteome during the recovery process.

PLOS PATHOGENS (2022)

Article Biochemical Research Methods

Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data

Zhiqiang Pang et al.

Summary: Liquid chromatography coupled with high-resolution mass spectrometry (LC-HRMS) is widely used in global metabolomics studies, but there are still challenges in data processing, statistical analysis, and functional interpretation. To overcome these barriers, the MetaboAnalyst platform has been updated to provide step-by-step instructions.

NATURE PROTOCOLS (2022)

Article Multidisciplinary Sciences

An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics

Matt Spick et al.

Summary: This study investigated the correlations between serum metabolites, salivary metabolites, and sebum lipids for the first time, and observed widespread alterations in serum-sebum lipid relationships in COVID-19 positive patients. The study also compared the ability of these biofluids to differentiate COVID-19 positive patients from controls, and found that serum performed best, followed by sebum, and saliva performed the worst.

SCIENTIFIC REPORTS (2022)

Article Nutrition & Dietetics

Relationships between plasma fatty acids in adults with mild, moderate, or severe COVID-19 and the development of post-acute sequelae

Sophia Stromberg et al.

Summary: This study investigated the association between plasma fatty acid levels and disease severity and post-acute sequelae of COVID-19 (PASC) in adults. The results showed significant differences in plasma fatty acid profiles among individuals with different disease severities. Modulating fatty acids may be beneficial for modifying the course of COVID-19, especially for overweight and severely ill adults.

FRONTIERS IN NUTRITION (2022)

Article Medical Informatics

Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study

Seul Kee Byeon et al.

Summary: In this retrospective cohort study, biomarkers that reliably predict severe and clinical outcomes of COVID-19 were discovered by analyzing samples from 455 participants. The study found that multiomic molecular signatures in plasma collected before hospital admission could be used to predict disease severity, demonstrating the potential of machine learning approaches in identifying novel clinical signatures.

LANCET DIGITAL HEALTH (2022)

Letter Dermatology

High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2

Xiaotong Xue et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Letter Infectious Diseases

Silent COVID-19: what your skin can reveal

Claudio Guarneri et al.

LANCET INFECTIOUS DISEASES (2021)

Article Chemistry, Analytical

Covid-19 Automated Diagnosis and Risk Assessment through Metabolomics and Machine Learning

Jeany Delafiori et al.

Summary: COVID-19 continues to pose a heavy burden worldwide, emphasizing the importance of patient screening and risk management. Our integration of machine learning algorithms with mass spectrometry led to the development of a rapid platform for distinguishing COVID-19 in plasma samples and providing tools for risk assessment, aiding in patient management and decision-making.

ANALYTICAL CHEMISTRY (2021)

Review Dermatology

Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives

Giovanni Genovese et al.

Summary: COVID-19 is a global pandemic caused by SARS-CoV-2, with common symptoms including fever, cough, fatigue, dyspnea, and hypogeusia/hyposmia. Dermatological manifestations have been increasingly reported, leading to a proposed classification of six main clinical patterns. This review summarizes the knowledge on these cutaneous manifestations, focusing on clinical features, therapeutic management, and hypothesized pathophysiological mechanisms.

DERMATOLOGY (2021)

Editorial Material Chemistry, Medicinal

CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections

M. F. Nagoor Meeran et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 continues to affect millions due to lack of drugs and vaccines. Therapeutic strategies involving activation of cannabinoid type-2 receptors (CB2R) have shown potential in suppressing hyperimmune-inflammatory responses, providing a promising avenue for further investigation and potential treatment against the virus.

DRUG DEVELOPMENT RESEARCH (2021)

Article Medicine, General & Internal

Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study

Stanislas Grassin-Delyle et al.

Summary: This study characterized the exhaled breath from mechanically ventilated adults with COVID-19 using real-time proton transfer reaction time-of-flight mass spectrometry. The analysis was able to differentiate between COVID-19 and non-COVID-19 ARDS with high accuracy. Characteristic volatile compounds were identified in the exhaled breath of COVID-19 patients, showing potential for early diagnosis.

EBIOMEDICINE (2021)

Article Multidisciplinary Sciences

Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19

Marianna Caterino et al.

Summary: This study utilized targeted lipidomic analysis coupled with proinflammatory cytokines and alarmins measurement to investigate the serum of COVID-19 patients with different severity degrees. The study measured serum IL-26, a cytokine involved in the IL-17 pathway, TSLP, and adiponectin, and correlated them with lipid profiles of COVID-19 patients, providing important insights for the classification of the disease and the identification of therapeutic targets.

SCIENTIFIC REPORTS (2021)

Article Microbiology

Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab

Gaia Meoni et al.

Summary: The research analyzed the metabolites of COVID-19 patients and controls using NMR, finding common plasma metabolomic and lipidomic signatures in COVID-19 patients. Tocilizumab treatment was shown to partially reverse the metabolic alterations caused by SARS-CoV-2 infection.

PLOS PATHOGENS (2021)

Article Biochemistry & Molecular Biology

Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients

Franziska Schmelter et al.

Summary: The metabolic serum profile of COVID-19 patients differs significantly from healthy controls and patients with cardiogenic shock. However, individuals with anti-SARS-CoV-2 antibodies but without severe disease do not show significant metabolic disturbances. This suggests that dyslipidemia may be a confounding risk factor for COVID-19 and could be used for patient stratification.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Biochemistry & Molecular Biology

Metabolomics Diagnosis of COVID-19 from Exhaled Breath Condensate

Elettra Barberis et al.

Summary: Researchers used metabolomics analysis of exhaled breath condensate to discover potential biomarkers for noninvasive diagnosis and monitoring of COVID-19. They found that fatty acids in EBC can differentiate COVID-19 patients and may have a protective effect, suggesting their potential use as a preventive strategy against the infection.

METABOLITES (2021)

Article Cell Biology

Biological and Clinical Factors Contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19

Angelo D'Alessandro et al.

Summary: This large study analyzed metabolic features of COVID-19 patients and found significant changes in amino acid and fatty acid/acylcarnitine metabolism as relevant markers of disease severity, progression, and prognosis. Machine learning models achieved around 78% prediction accuracy when trained with metabolomics and clinical data from half of the patient cohort, providing a foundation for further research and data sharing opportunities.

CELLS (2021)

Article Multidisciplinary Sciences

Distinct lipid metabolic dysregulation in asymptomatic COVID-19

Yanhong Hao et al.

Summary: By performing comprehensive lipidomic characterization of serum samples from asymptomatic COVID-19 patients and healthy controls, a panel of key lipids that could accurately identify asymptomatic patients was screened out, revealing unique lipid metabolic dysregulation.

ISCIENCE (2021)

Article Medicine, General & Internal

Changes to the sebum lipidome upon COVID-19 infection observed via rapid sampling from the skin

Matt Spick et al.

Summary: The study revealed lower lipid levels in COVID-19 positive patients, indicating dyslipidemia. Sebum sampling showed potential for distinguishing between COVID-19 positive and negative patients based on lipidomic analysis.

ECLINICALMEDICINE (2021)

Article Biochemistry & Molecular Biology

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

Bo Shen et al.

Review Biochemistry & Molecular Biology

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

Francesca Rossi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Plasma metabolomic and lipidomic alterations associated with COVID-19

Di Wu et al.

NATIONAL SCIENCE REVIEW (2020)

Review Dermatology

Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems

Suruchi Garg et al.

DERMATOLOGIC THERAPY (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum

Chiara Bruzzone et al.

ISCIENCE (2020)

Article Chemistry, Analytical

Saliva NMR-Based Metabolomics in the War Against COVID-19

Gilson Costa dos Santos Junior et al.

ANALYTICAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Yapeng Su et al.

Review Geriatrics & Gerontology

Age-related mitochondrial dysfunction as a key factor in COVID-19 disease

Daniel J. Moreno Fernandez-Ayala et al.

EXPERIMENTAL GERONTOLOGY (2020)

Article Biochemistry & Molecular Biology

Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2

Elettra Barberis et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Pediatrics

Skin Biomarkers for Cystic Fibrosis: A Potential Non-Invasive Approach for Patient Screening

Cibele Zanardi Esteves et al.

FRONTIERS IN PEDIATRICS (2018)

Review Endocrinology & Metabolism

Immunoregulatory Role of Cannabinoids during Infectious Disease

Rosalia Hernandez-Cervantes et al.

NEUROIMMUNOMODULATION (2017)

Article Medical Laboratory Technology

Serum metabonomics of NAFLD plus T2DM based on liquid chromatography-mass spectrometry

Yang Chen et al.

CLINICAL BIOCHEMISTRY (2016)

Review Biochemistry & Molecular Biology

Endogenous cannabinoids revisited: A biochemistry perspective

B. M. Fonseca et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)

Review Cardiac & Cardiovascular Systems

Oleamide: A fatty acid amide signaling molecule in the cardiovascular system ?

C. Robin Hiley et al.

CARDIOVASCULAR DRUG REVIEWS (2007)

Article Computer Science, Artificial Intelligence

Random forests

L Breiman

MACHINE LEARNING (2001)